609
Views
0
CrossRef citations to date
0
Altmetric
Chronic Kidney Disease and Progression

Serum hydroxycotinine was associated with chronic kidney disease (CKD): a cross-sectional study based on NHANES

, , &
Article: 2356024 | Received 05 Dec 2023, Accepted 12 May 2024, Published online: 04 Jun 2024

References

  • Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. JAMA. 2019;322(13):1294–1304. doi: 10.1001/jama.2019.14745.
  • Webster AC, Nagler EV, Morton RL, et al. Chronic kidney disease. Lancet. 2017;389(10075):1238–1252. doi: 10.1016/S0140-6736(16)32064-5.
  • Hannan M, Ansari S, Meza N, et al. Risk factors for CKD progression: overview of findings from the CRIC study. Clin J Am Soc Nephrol. 2021;16(4):648–659.
  • Gregg LP, Hedayati SS. Management of traditional cardiovascular risk factors in CKD: what are the data? Am J Kidney Dis. 2018;72(5):728–744. doi: 10.1053/j.ajkd.2017.12.007.
  • Centner AM, Bhide PG, Salazar G. Nicotine in senescence and atherosclerosis. Cells. 2020;9(4):1035. doi: 10.3390/cells9041035.
  • Kondo T, Nakano Y, Adachi S, et al. Effects of tobacco smoking on cardiovascular disease. Circ J. 2019;83(10):1980–1985. doi: 10.1253/circj.CJ-19-0323.
  • Campbell BCV, Khatri P. Stroke. Lancet. 2020;396(10244):129–142. doi: 10.1016/S0140-6736(20)31179-X.
  • Hecht SS, Hatsukami DK. Smokeless tobacco and cigarette smoking: chemical mechanisms and cancer prevention. Nat Rev Cancer. 2022;22(3):143–155. doi: 10.1038/s41568-021-00423-4.
  • Münzel T, Hahad O, Kuntic M, et al. Effects of tobacco cigarettes, e-cigarettes, and waterpipe smoking on endothelial function and clinical outcomes. Eur Heart J. 2020;41(41):4057–4070. doi: 10.1093/eurheartj/ehaa460.
  • Jain G, Jaimes EA. Nicotine signaling and progression of chronic kidney disease in smokers. Biochem Pharmacol. 2013;86(8):1215–1223. doi: 10.1016/j.bcp.2013.07.014.
  • Sosnoff CS, Caron K, Akins JR, et al. Serum concentrations of cotinine and trans-3'-hydroxycotinine in US adults: results from wave 1 (2013-2014) of the population assessment of tobacco and health study. Nicotine Tob Res. 2022;24(5):736–744. doi: 10.1093/ntr/ntab240.
  • Gu F, Derkach A, Freedman ND, et al. Cigarette smoking behaviour and blood metabolomics. Int J Epidemiol. 2016;45(5):1421–1432.
  • Keith RJ, Riggs DW, Conklin DJ, et al. Nicotine metabolism in adults with type 2 diabetes. Nicotine Tob Res. 2019;21(6):846–849. doi: 10.1093/ntr/ntx214.
  • Lee J, Oh S, Kang H, et al. Environment-wide association study of CKD. Clin J Am Soc Nephrol. 2020;15(6):766–775.
  • Eid HA, Moazen EM, Elhussini M, et al. The influence of smoking on renal functions among apparently healthy smokers. J Multidiscip Healthc. 2022;15:2969–2978.
  • Sanders AP, Mazzella MJ, Malin AJ, et al. Combined exposure to lead, cadmium, mercury, and arsenic and kidney health in adolescents age 12-19 in NHANES 2009-2014. Environ Int. 2019;131:104993.
  • Grubbs V, Plantinga LC, Tuot DS, et al. Americans’ use of dietary supplements that are potentially harmful in CKD. Am J Kidney Dis. 2013;61(5):739–747.
  • Meeusen JW, Kasozi RN, Larson TS, et al. Clinical impact of the refit CKD-EPI 2021 creatinine-based eGFR equation. Clin Chem. 2022;68(4):534–539. doi: 10.1093/clinchem/hvab282.
  • Eke PI, Dye BA, Wei L, et al. Update on prevalence of periodontitis in adults in the United States: NHANES 2009 to 2012. J Periodontol. 2015;86(5):611–622.
  • Fu Z, Zhou T, Dong F, et al. Secondhand smoke is positively associated with pre-frailty and frailty in non-smoking older adults. Front Psychiatry. 2022;13:1095254. doi: 10.3389/fpsyt.2022.1095254.
  • Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018;126(5):1763–1768. doi: 10.1213/ANE.0000000000002864.
  • Benedetto U, Head SJ, Angelini GD, et al. Statistical primer: propensity score matching and its alternatives. Eur J Cardiothorac Surg. 2018;53(6):1112–1117. doi: 10.1093/ejcts/ezy167.
  • Lusa L, Ahlin C. Restricted cubic splines for modelling periodic data. PLoS One. 2020;15(10):e0241364. doi: 10.1371/journal.pone.0241364.
  • Wang Y, Narayanapillai SC, Hu Q, et al. Detection and quantification of 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB) from smoker albumin and its potential as a surrogate biomarker of tobacco-specific nitrosamines exposure and bioactivation. Toxicol Lett. 2019;311:11–16. doi: 10.1016/j.toxlet.2019.04.020.
  • Kelly JT, Su G, Zhang L, et al. Modifiable lifestyle factors for primary prevention of CKD: a systematic review and Meta-Analysis. J Am Soc Nephrol. 2021;32(1):239–253.
  • Kobeissy F, Shaito A, Kaplan A, et al. Acute exposure to cigarette smoking followed by myocardial infarction aggravates renal damage in an in vivo mouse model. Oxid Med Cell Longev. 2017;2017:5135241.
  • Stangenberg S, Nguyen LT, Chen H, et al. Oxidative stress, mitochondrial perturbations and fetal programming of renal disease induced by maternal smoking. Int J Biochem Cell Biol. 2015;64:81–90.
  • Lee S, Kang S, Joo YS, et al. Smoking, smoking cessation, and progression of chronic kidney disease: results from KNOW-CKD study. Nicotine Tob Res. 2021;23(1):92–98. doi: 10.1093/ntr/ntaa071.
  • García-Esquinas E, Loeffler LF, Weaver VM, et al. Kidney function and tobacco smoke exposure in US adolescents. Pediatrics. 2013;131(5):e1415–e1423. doi: 10.1542/peds.2012-3201.
  • Wang L, Smith-Salzberg B, Meyers KE, et al. Tobacco exposure in adults and children with proteinuric glomerulopathies: a NEPTUNE cohort study. BMC Nephrol. 2023;24(1):30. doi: 10.1186/s12882-023-03073-w.